Kostenloser Aktien-Screener
Load Speichern Erstellen Sie eine Watchlist Help| Symbol | Unternehmen | Börse | Industrie | Marktkapitalisierung | EBITDA | P / E | EV / EBITDA | Verschuldung / Eigenkapital | Durchschnittsvolumen | Institutionelles Eigentum | Verdienstdatum | Preis | Leistung heute |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| UNH | Unitedhealth Group Inc | NYSE | Managed Health Care | $503.80B | $36.019B | 38.60 | 16.90 | 1.97 | N/A | 90.12% | 11 Oct 2024 | $589.75 | -1.55% |
| UNH | UnitedHealth Group Incorporated | XETRA | Healthcare Plans | $499.33B | $29.351B | 35.41 | 18.21 | 1.77 | 631.000 | 89.62% | N/A | €537.80 | +1.47% |
| JNJ | Johnson & Johnson | NYSE | Pharmaceuticals | $459.47B | $32.631B | 10.82 | 14.31 | 1.44 | 9.493M | 70.32% | 15 Oct 2024 | $164.82 | -1.53% |
| LLY | Lilly(Eli) & Co | NYSE | Pharmaceuticals | $343.00B | $15.041B | 112.99 | 61.85 | 4.93 | N/A | 84.30% | 30 Oct 2024 | $920.89 | +2.18% |
| NONOF | Novo Nordisk A/S | OTC | Biotechnologie | $294.46B | kr77.649B | 38.21 | 27.54 | 1.75 | 49.546k | 41.07% | N/A | $131.54 | +0.00% |
| NVO | Novo Nordisk | NYSE | Biotechnologie | $293.86B | N/A | 55.20 | N/A | N/A | 4.944M | 8.30% | 6 Nov 2024 | $135.23 | +4.20% |
| PFE | Pfizer Inc. | NYSE | Pharmaceuticals | $291.64B | $39.014B | N/A | 5.57 | 1.54 | 5.921M | 69.08% | 29 Oct 2024 | $29.66 | -0.27% |
| ABBV | Abbvie Inc | NYSE | Pharmaceuticals | $288.27B | $22.237B | 64.86 | 18.20 | 12.00 | N/A | 71.44% | 25 Oct 2024 | $194.59 | -2.39% |
| 4AB | AbbVie Inc. | XETRA | Drug Manufacturers - General | $283.27B | $27.170B | 53.48 | 12.49 | 11.96 | 617.000 | 71.44% | N/A | €177.20 | -0.15% |
| RHHBY | Roche Holding AG | OTC | Pharmaceuticals | $280.28B | CHF23.955B | 23.57 | 11.78 | 2.61 | 1.981M | 1.27% | N/A | $37.33 | -5.99% |
| RHHVF | Roche Holding AG | OTC | Pharmaceuticals | $278.66B | CHF23.955B | 25.25 | 11.57 | 1.72 | 9.306k | 38.17% | N/A | $316.22 | +5.69% |
| MRK | Merck & Co Inc | NYSE | Pharmaceuticals | $276.92B | $20.142B | 21.20 | 15.90 | 1.84 | N/A | 75.30% | 31 Oct 2024 | $114.71 | -0.54% |
| NOVC | Novo Nordisk A/S | XETRA | Biotechnologie | $276.66B | N/A | 37.82 | 3.35 | N/A | 83.976k | N/A | N/A | €182.98 | -0.71% |
| MRK | Merck & Co., Inc. | EURONEXT | Pharmaceuticals | $273.78B | $24.074B | 19.93 | 12.15 | 1.83 | 0.000 | 76.35% | N/A | €101.40 | +0.00% |
| AZN | AstraZeneca Plc | LSE | Pharmaceuticals | $215.98B | $12.522B | 33.54 | 17.49 | 1.58 | 1.543M | 49.18% | N/A | GBX12,202.00 | -0.86% |
| AZN | AstraZeneca PLC | NASDAQ | Drug Manufacturers - General | $215.52B | $12.522B | 38.81 | 17.81 | 1.58 | 3.433M | 18.45% | N/A | $80.53 | -0.78% |
| AZN | Astrazeneca plc | NYSE | Pharmaceuticals | $215.24B | $12.929B | 98.21 | 22.56 | 1.58 | N/A | 17.84% | 12 Nov 2024 | $80.53 | -0.78% |
| TN8 | Thermo Fisher Scientific Inc. | XETRA | Life Sciences Tools & Services | $211.41B | $12.354B | 32.37 | 19.31 | 1.33 | 186.000 | 90.99% | N/A | €555.90 | -2.13% |
| TMO | Thermo Fisher Scientific Inc. | NYSE | Life Sciences Tools & Services | $210.98B | $10.352B | 38.25 | 23.55 | 1.11 | 1.241M | 90.48% | 23 Oct 2024 | $618.46 | -0.92% |
| ZEG | AstraZeneca Plc | XETRA | Pharmaceuticals | $210.39B | $12.522B | 57.94 | 18.39 | 1.68 | 9.087k | 47.18% | N/A | €144.80 | -0.58% |
| NVSEF | Novartis AG | OTC | Pharmaceuticals | $205.84B | $16.100B | 12.73 | 12.11 | 1.14 | 19.318k | 32.31% | N/A | $114.53 | -0.41% |
| NVS | Novartis AG | NYSE | Pharmaceuticals | $203.64B | $21.982B | 22.56 | 12.65 | 1.14 | 1.156M | 9.20% | 29 Oct 2024 | $115.28 | -1.46% |
| ABT | Abbott Laboratories | NYSE | Health Care Equipment | $190.11B | $8.402B | 36.67 | 23.96 | 0.89 | N/A | 75.68% | 16 Oct 2024 | $116.60 | -0.44% |
| DAP | Danaher Corporation | XETRA | Life Sciences Tools & Services | $189.36B | $10.896B | 29.33 | 19.23 | 0.91 | 478.000 | 80.55% | N/A | €246.35 | +0.68% |
| DHR | Danaher Corp. | NYSE | Life Sciences Tools & Services | 187.21B$ | $6.672B | 47.80 | 31.54 | 0.58 | N/A | 80.74% | 29 Oct 2024 | $271.98 | -1.00% |
| ABL | Abbott Laboratories | XETRA | Health Care Equipment | $181.83B | $13.121B | 25.49 | 14.34 | 1.09 | 748.000 | 75.55% | N/A | €105.10 | -0.64% |
| BMY | Bristol-Myers Squibb Co. | NYSE | Pharmaceuticals | $167.61B | $16.796B | N/A | 8.57 | 2.23 | 10.938M | 79.37% | 31 Oct 2024 | $48.59 | -1.40% |
| BRM | Bristol-Myers Squibb Company | XETRA | Pharmaceuticals | $164.82B | $20.383B | 16.32 | 10.17 | 2.04 | 4.308k | 78.19% | N/A | €44.08 | +0.05% |
| AMGN | AMGEN Inc. | NASDAQ | Pharmaceuticals | $153.35B | $11.266B | 56.41 | 20.43 | 14.59 | N/A | 82.11% | 5 Nov 2024 | $329.98 | +0.32% |
| AMG | Amgen, Inc. | XETRA | Pharmaceuticals | $144.23B | 13.178B$ | N/A | 12.95 | 2.24 | 529.000 | 81.50% | N/A | €294.35 | -0.24% |
| CVS | CVS Health Corp | NYSE | Managed Health Care | $132.29B | $19.758B | 9.95 | 7.18 | 2.26 | N/A | 80.32% | 6 Nov 2024 | $56.11 | -1.46% |
| CVS | CVS Health Corporation | XETRA | Healthcare Plans | $129.56B | $18.835B | 18.02 | 9.51 | 2.26 | 660.000 | 80.32% | N/A | €51.09 | +2.30% |
| SNY | Sanofi | NYSE | Pharmaceuticals | $122.03B | €12.023B | 6.14 | 10.52 | 0.69 | 2.315M | 10.41% | N/A | $57.46 | -1.15% |
| ANTM | Anthem Inc | NYSE | Managed Health Care | $117.13B | $9.393B | 18.76 | 14.86 | 2.79 | N/A | 92.41% | N/A | $482.58 | +2.70% |
| SAN | Sanofi | EURONEXT | Pharmaceuticals | $116.85B | €12.023B | 10.80 | 10.68 | 0.75 | 1.542M | 45.06% | N/A | €103.78 | -0.75% |
| SNY | Sanofi | NASDAQ | Drug Manufacturers - General | $114.45B | €13.168B | 29.62 | 9.61 | 0.70 | 2.278M | 10.08% | N/A | $57.46 | -1.15% |
| SNW | Sanofi | XETRA | Drug Manufacturers—General | $113.60B | €12.023B | 10.87 | 10.23 | 0.75 | 2.546k | 45.06% | N/A | €103.92 | -1.22% |
| GILD | Gilead Sciences, Inc. | NASDAQ | Pharmaceuticals | $112.22B | $12.178B | 95.22 | 9.78 | 1.72 | N/A | 82.11% | 7 Nov 2024 | $80.94 | -0.61% |
| CI | Cigna Group (The) | NYSE | Managed Health Care | $109.85B | $10.716B | 27.80 | 11.91 | 2.30 | N/A | 92.26% | 31 Oct 2024 | $357.78 | -0.09% |
| GIS | Gilead Sciences, Inc. | XETRA | Pharmaceuticals | $107.73B | $12.775B | 43.15 | 9.92 | 2.26 | 1.842k | 82.19% | N/A | €73.32 | +0.97% |
| GS7 | GlaxoSmithKline Plc | XETRA | Pharmaceuticals | $106.14B | £10.817B | 21.44 | 9.90 | 3.61 | 109.617k | 44.16% | N/A | €16.478 | -18.83% |
| MDT | Medtronic Plc | NYSE | Health Care Equipment | $104.80B | $7.213B | 30.32 | 17.93 | 0.79 | N/A | 83.28% | 19 Nov 2024 | $90.35 | -0.70% |
| 2M6 | Medtronic Plc | XETRA | Health Care Equipment | $101.95B | $8.761B | 25.96 | 13.62 | 0.78 | 974.000 | 83.28% | N/A | €82.09 | +0.93% |
| CGN | Cigna Corporation | XETRA | Healthcare Plans | $99.33B | $10.227B | 14.16 | 12.05 | 2.29 | 4.000 | 91.10% | N/A | €263.60 | -0.42% |
| ISRG | Intuitive Surgical Inc | NASDAQ | Health Care Supplies | $99.18B | $2.008B | 82.93 | 51.22 | 0.15 | N/A | 87.25% | 17 Oct 2024 | $490.93 | +1.38% |
| CSL | CSL Limited | ASX | Biotechnologie | $96.86B | $3.325B | 36.66 | 28.24 | 0.96 | 698.660k | 33.93% | N/A | AUD$301.66 | +0.60% |
| CSLLY | CSL Ltd. | OTC | Biotechnologie | $94.78B | $3.325B | 47.73 | 29.07 | 0.94 | 23.214k | 0.08% | N/A | $100.86 | -0.06% |
| SYK | Stryker Corp. | NYSE | Health Care Equipment | $92.42B | $4.147B | 40.39 | 28.98 | 1.15 | 1.803M | 78.51% | 29 Oct 2024 | $366.35 | +0.36% |
| GLAXF | GlaxoSmithKline Plc | OTC | Pharmaceuticals | $91.11B | £11.112B | 18.40 | 6.66 | 3.61 | 1.607k | 44.16% | N/A | $21.48 | +0.00% |
| ESLOF | EssilorLuxottica SA | OTC | Health Care Supplies | $84.36B | €4.902B | 1,005.46 | 19.00 | 0.67 | 561.000 | 27.64% | N/A | $230.25 | +0.00% |
Sign up
